These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17283749)

  • 21. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.
    Koch M; Dezi A; Ferrario F; Capurso I
    Arch Intern Med; 1996 Nov; 156(20):2321-32. PubMed ID: 8911239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of NSAID-induced ulcers in the elderly.
    Geriatrics; 2005 Oct; Suppl():3-12; quiz 13-4. PubMed ID: 16334635
    [No Abstract]   [Full Text] [Related]  

  • 23. Over the counter H2 receptor antagonists. Serve only as expensive antacids.
    Douds AC; Maxwell JD
    BMJ; 1994 Oct; 309(6962):1156. PubMed ID: 7987114
    [No Abstract]   [Full Text] [Related]  

  • 24. Soothing the burn. Modern management of GERD.
    Covington C
    Adv Nurse Pract; 2001 Jul; 9(7):65-8, 70, 72 passim. PubMed ID: 12420457
    [No Abstract]   [Full Text] [Related]  

  • 25. [The use of histamine H2 receptor blockaders in gastroenterology].
    Waldum HL; Petersen H
    Tidsskr Nor Laegeforen; 1983 Apr; 103(12):980-3. PubMed ID: 6136102
    [No Abstract]   [Full Text] [Related]  

  • 26. Treating peptic ulcer: an ongoing challenge.
    Cohen MH
    J Am Osteopath Assoc; 1995 Apr; 95(4):239-41. PubMed ID: 7744624
    [No Abstract]   [Full Text] [Related]  

  • 27. Modern management of dyspepsia.
    Talley NJ
    Aust Fam Physician; 1996 Jan; 25(1):47-52. PubMed ID: 8607775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical treatment of gastroesophageal reflux disease: options and priorities.
    Thomson AB
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():14-23. PubMed ID: 1349550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Famotidine to prevent peptic ulcer caused by NSAIDs.
    Graham DY
    N Engl J Med; 1996 Oct; 335(17):1322; author reply 1322-3. PubMed ID: 8992333
    [No Abstract]   [Full Text] [Related]  

  • 30. Systematic review: Antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia.
    Moayyedi P; Soo S; Deeks J; Forman D; Harris A; Innes M; Delaney B
    Aliment Pharmacol Ther; 2003 May; 17(10):1215-27. PubMed ID: 12755835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of peptic ulcer disease and nonulcer dyspepsia.
    Meurer LN
    J Fam Pract; 2001 Jul; 50(7):614-9. PubMed ID: 11485712
    [No Abstract]   [Full Text] [Related]  

  • 32. Options in the treatment and prevention of NSAID-induced gastroduodenal mucosal damage.
    Agrawal NM; Dajani EZ
    J Rheumatol Suppl; 1990 Feb; 20():7-11. PubMed ID: 1969964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Self medication with antacids and H2 antihistaminics].
    Martin E
    Pharm Unserer Zeit; 2007; 36(1):52-8. PubMed ID: 17283751
    [No Abstract]   [Full Text] [Related]  

  • 34. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
    Yeomans ND
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S89-92. PubMed ID: 10379475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antacids vs. antacids plus non-prescription ranitidine for heartburn during pregnancy.
    Rayburn W; Liles E; Christensen H; Robinson M
    Int J Gynaecol Obstet; 1999 Jul; 66(1):35-7. PubMed ID: 10458549
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacological bases of the medical treatment of gastroesophageal reflux disease.
    Scarpignato C
    Dig Dis; 1988; 6(3):117-48. PubMed ID: 2898983
    [No Abstract]   [Full Text] [Related]  

  • 37. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer.
    Farrow DC; Vaughan TL; Sweeney C; Gammon MD; Chow WH; Risch HA; Stanford JL; Hansten PD; Mayne ST; Schoenberg JB; Rotterdam H; Ahsan H; West AB; Dubrow R; Fraumeni JF; Blot WJ
    Cancer Causes Control; 2000 Mar; 11(3):231-8. PubMed ID: 10782657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current role of acid suppressants in the treatment of peptic ulcer disease].
    Takeda H
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():371-6. PubMed ID: 11979809
    [No Abstract]   [Full Text] [Related]  

  • 39. [Peptic ulcer and drug therapy].
    Tsuneoka K
    Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):1-2. PubMed ID: 1673699
    [No Abstract]   [Full Text] [Related]  

  • 40. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
    Sontag SJ
    Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.